<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0121-8123</journal-id>
<journal-title><![CDATA[Revista Colombiana de Reumatología]]></journal-title>
<abbrev-journal-title><![CDATA[Rev.Colomb.Reumatol.]]></abbrev-journal-title>
<issn>0121-8123</issn>
<publisher>
<publisher-name><![CDATA[Asociación Colombiana de Reumatología]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0121-81232010000400003</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Insuficiencia de vitamina D en pacientes adultos con baja masa ósea y osteoporosis en la Fundación Santa Fe de Bogotá 2008-2009]]></article-title>
<article-title xml:lang="en"><![CDATA[Vitamin D insufficiency in adults patients with low bone mass and osteoporosis in the Fundación Santa Fe de Bogotá 2008-2009]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[González Devia]]></surname>
<given-names><![CDATA[Deyanira]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Zúñiga Libreros]]></surname>
<given-names><![CDATA[Claudia]]></given-names>
</name>
<xref ref-type="aff" rid="A02"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Kattah Calderón]]></surname>
<given-names><![CDATA[William]]></given-names>
</name>
<xref ref-type="aff" rid="A03"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,Hospital Universitario Fundación Santa Fe de Bogotá grupo hueso saludable de la FSFB Universidad de los Andes]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<aff id="A02">
<institution><![CDATA[,Universidad del Rosario  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<aff id="A03">
<institution><![CDATA[,Hospital Universitario Fundación Santa Fe de Bogotá Departamento de Medicina Interna sección de endocrinología]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>09</month>
<year>2010</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>09</month>
<year>2010</year>
</pub-date>
<volume>17</volume>
<numero>4</numero>
<fpage>212</fpage>
<lpage>218</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_arttext&amp;pid=S0121-81232010000400003&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_abstract&amp;pid=S0121-81232010000400003&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.co/scielo.php?script=sci_pdf&amp;pid=S0121-81232010000400003&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[La hipovitaminosis D se asocia con osteoporosis, enfermedades neuromusculares, autoinmunes y cáncer. La prevalencia oscila entre 11% y 70% en diferentes poblaciones estudiadas. Debido a que la osteoporosis es una enfermedad frecuente, determinamos la prevalencia de hipovitaminosis D asociada a desmineralización ósea en población atendida en la FSFB entre agosto de 2008 y julio de 2009; revisamos edad, género, T-Score, Z-score. Se consideró como rango normal de 25OHD entre 32 y 150 ng/dl. Hallamos 460 determinaciones de 25OHD, 105 sujetos con osteodensitometría DXA, 80% mujeres. Edad promedio 66 años (DE ± 12,5; rango 39 a 91); para mujeres fue 67,1 años (DE ± 12,2; rango 39 a 91), para hombres fue 61 años (DE ± 10,7; rango 42 a 82). Los niveles de 25OHD promedio fueron de 31 ng/ml (DE ± 17,6; rango 8,2 a 110); para mujeres 30,5 ng/ml (DE ± 16,1; rango 10,6 a 96 ng/ml), para hombres 33,5 ng/ml (DE ± 23,4; rango 8,2 a 110 ng/ml). El 69,5% de casos presentaron algún nivel de insuficiencia de vitamina D, 45,7% insuficiencia leve y 23,8% insuficiencia moderada; no hay casos con insuficiencia severa. No hubo diferencias significativas entre concentraciones de 25OHD entre hombres y mujeres; o edad. La osteoporosis se correlaciona con niveles de 25OHD inferiores a 28 ng/ml (P= 0,046), pero no hay correlación entre niveles bajos de 25OHD y osteopenia. La hipovitaminosis D es muy prevalente en pacientes con osteoporosis y baja masa ósea y debe evaluarse en el contexto de osteoporosis.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Hypovitaminosis D is associated with osteoporosis, neuromuscular diseases, autoimmune diseases and cancer. The prevalence varies from 11-70% in different populations. Due osteoporosis is a common disease, we determined the prevalence of hypovitaminosis D associated with bone demineralization in FSFB population evaluated between August 2008 and July 2009, we reviewed age, gender, T-Score, Z-score. Values between 32-150 ng/ml were considered as normal. We found 460 25OHD results, 105 subjects with mineral density for DXA method, 80% female. Mean age for women was 66 years (SD ± 12.5, range 39-91) for women was 67.1 years (SD ± 12.2, range 39-91) for men was 61 years (SD ± 10.7, range 42-82). Mean 25OHD levels were 31 ng / ml (SD ± 17.6, range 8.2 to 110), for women 30.5 ng / mL (SD ± 16.1, range 10.6 to 96 ng / mL), for men 33.5 ng / mL (SD ± 23.4, range 8.2 to 110 ng / mL). 69,5% of cases were considered as vitamin D insufficiency, 45,7% mild, 23,8% moderate, and no cases of severe déficit. No significant difference between 25OHD concentrations and gender, or age were considered. Osteoporosis was correlated with 25OHD levels below 28 ng/ml (P=0,046) but not between low 25OHD and subjects with osteopenia. The vitamin D deficiency is highly prevalent in patients with osteoporosis and low bone mass and should be evaluated in the context of osteoporosis.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[vitamina D]]></kwd>
<kwd lng="es"><![CDATA[osteoporosis]]></kwd>
<kwd lng="es"><![CDATA[baja masa ósea]]></kwd>
<kwd lng="es"><![CDATA[osteopenia]]></kwd>
<kwd lng="en"><![CDATA[vitamin D]]></kwd>
<kwd lng="en"><![CDATA[osteoporosis]]></kwd>
<kwd lng="en"><![CDATA[osteopenia]]></kwd>
<kwd lng="en"><![CDATA[low bone density]]></kwd>
</kwd-group>
</article-meta>
</front><body><![CDATA[  ]]></body><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Elliott]]></surname>
<given-names><![CDATA[ME]]></given-names>
</name>
<name>
<surname><![CDATA[Binkley]]></surname>
<given-names><![CDATA[NC]]></given-names>
</name>
<name>
<surname><![CDATA[Carnes]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Fracture risks for women in long-term care: high prevalence of calcaneal osteoporosis and hypovitaminosis D]]></article-title>
<source><![CDATA[Pharmacotherapy]]></source>
<year>2003</year>
<volume>23</volume>
<page-range>702-710</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Semba]]></surname>
<given-names><![CDATA[RD]]></given-names>
</name>
<name>
<surname><![CDATA[Garrett]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Johnson]]></surname>
<given-names><![CDATA[BA]]></given-names>
</name>
<name>
<surname><![CDATA[Guralnik]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Fried]]></surname>
<given-names><![CDATA[LP]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Vitamin D deficiency among older women with and without disability]]></article-title>
<source><![CDATA[Am J Clin Nutr]]></source>
<year>2000</year>
<volume>72</volume>
<page-range>1529-1534</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bolland]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Grey]]></surname>
<given-names><![CDATA[AB]]></given-names>
</name>
<name>
<surname><![CDATA[Ames]]></surname>
<given-names><![CDATA[RW]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[The effects of seasonal variation of 25-hydroxyvitamin D and fat mass on a diagnosis of vitamin D sufficiency]]></article-title>
<source><![CDATA[Am J Clin Nutr]]></source>
<year>2007</year>
<volume>86</volume>
<page-range>959-964</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Holick]]></surname>
<given-names><![CDATA[M F.]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Vitamin D deficiency]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2007</year>
<volume>357</volume>
<page-range>266-281</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kuchuk]]></surname>
<given-names><![CDATA[NO]]></given-names>
</name>
<name>
<surname><![CDATA[van Schoor]]></surname>
<given-names><![CDATA[NM]]></given-names>
</name>
<name>
<surname><![CDATA[Pluijm]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
<name>
<surname><![CDATA[Chines]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Lips]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Vitamin D status, parathyroid function, bone turnover, and BMD in postmenopausal women with osteoporosis: global perspective]]></article-title>
<source><![CDATA[J Bone Miner Res]]></source>
<year>2009</year>
<volume>24</volume>
<page-range>693-701</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hart]]></surname>
<given-names><![CDATA[GR]]></given-names>
</name>
<name>
<surname><![CDATA[Furniss]]></surname>
<given-names><![CDATA[JL]]></given-names>
</name>
<name>
<surname><![CDATA[Laurie]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Durham]]></surname>
<given-names><![CDATA[SK]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Measurement of vitamin D status: background, clinical use, and methodologies]]></article-title>
<source><![CDATA[Clin Lab]]></source>
<year>2006</year>
<volume>52</volume>
<page-range>335-343</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Glendenning]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Taranto]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Noble]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Current assays overestimate 25-hydroxyvitamin D3 and underestimate 25-hydroxyvitamin D2 compared with HPLC: need for assay-specific decision limits and metabolite-specific assays]]></article-title>
<source><![CDATA[Ann Clin Biochem]]></source>
<year>2006</year>
<volume>43</volume>
<page-range>23-30</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vieth]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Problems with direct 25-hydroxyvitamin D assays, and the target amount of vitamin D nutrition desirable for patients with osteoporosis]]></article-title>
<source><![CDATA[Osteoporos Int]]></source>
<year>2000</year>
<volume>11</volume>
<page-range>635-636</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="">
<collab>The DEQAS</collab>
<source><![CDATA[Vitamin D external quality assessment scheme]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Saenger]]></surname>
<given-names><![CDATA[AK]]></given-names>
</name>
<name>
<surname><![CDATA[Laha]]></surname>
<given-names><![CDATA[TJ]]></given-names>
</name>
<name>
<surname><![CDATA[Bremner]]></surname>
<given-names><![CDATA[DE]]></given-names>
</name>
<name>
<surname><![CDATA[Sadrzadeh]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Quantification of serum 25-hydroxyvitamin D2 and D3 using HPLC-tandem mass spectrometry and examination of reference intervals for diagnosis of vitamin D deficiency]]></article-title>
<source><![CDATA[Am J Clin Pathol]]></source>
<year>2006</year>
<volume>125</volume>
<page-range>914-920</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hollis]]></surname>
<given-names><![CDATA[BW]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Comparison of Commercially Available 125I-based RIA Methods for the Determination of Circulating 25-Hydroxyvitamin D]]></article-title>
<source><![CDATA[Clin Chem]]></source>
<year>2000</year>
<volume>46</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>1657-1661</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lensmeyer]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Wiebe]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Binkley]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Drezner]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[HPLC method for 25 hydroxyvitamin D measurement: comparison with contemporary assays]]></article-title>
<source><![CDATA[Clin Chem]]></source>
<year>2006</year>
<volume>52</volume>
<page-range>1120-1126</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Maunsell]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
<name>
<surname><![CDATA[Wright]]></surname>
<given-names><![CDATA[DJ]]></given-names>
</name>
<name>
<surname><![CDATA[Rainbow]]></surname>
<given-names><![CDATA[SJ]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Routine isotopedilution liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of the 25-hydroxy metabolites of vitamins D2 and D3]]></article-title>
<source><![CDATA[Clin Chem]]></source>
<year>2005</year>
<volume>51</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>1683-1690</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Horst]]></surname>
<given-names><![CDATA[RL]]></given-names>
</name>
<name>
<surname><![CDATA[Hollis]]></surname>
<given-names><![CDATA[BW]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Vitamin D assays and their clinical utility]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Holick]]></surname>
<given-names><![CDATA[MF]]></given-names>
</name>
</person-group>
<source><![CDATA[Physiology, Molecular Biology, and Clinical Applications]]></source>
<year>1999</year>
<page-range>239-271</page-range><publisher-loc><![CDATA[Totowa^eNJ NJ]]></publisher-loc>
<publisher-name><![CDATA[Humana Press Inc]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Souberbielle]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
<name>
<surname><![CDATA[Fayol]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Sault]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Lawson-Body]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Kahan]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Cormier]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Assay-specific decision limits for two new automated parathyroid hormone and 25-hydroxyvitamin D assays]]></article-title>
<source><![CDATA[Clin Chem]]></source>
<year>2005</year>
<volume>51</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>395-400</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Phinney]]></surname>
<given-names><![CDATA[KW]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Development of a standard reference material for vitamin D in Serum]]></article-title>
<source><![CDATA[Am J Clin Nutr]]></source>
<year>2008</year>
<numero>^s88</numero>
<issue>^s88</issue>
<supplement>88</supplement>
<page-range>511S-512S</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carter]]></surname>
<given-names><![CDATA[GD]]></given-names>
</name>
<name>
<surname><![CDATA[Carter]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Jones]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Berry]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[accurate are assays for 25-hydroxyvitamin D? Data from the international vitamin D external quality assessment scheme]]></article-title>
<source><![CDATA[Clin Chem]]></source>
<year>2004</year>
<volume>50</volume>
<page-range>2195-2197</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Looker]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
<name>
<surname><![CDATA[Dawson-Hughes]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Calvo]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III]]></article-title>
<source><![CDATA[Bone]]></source>
<year>2002</year>
<volume>30</volume>
<page-range>771-777</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Saraiva]]></surname>
<given-names><![CDATA[GL]]></given-names>
</name>
<name>
<surname><![CDATA[Cendoroglo]]></surname>
<given-names><![CDATA[MS]]></given-names>
</name>
<name>
<surname><![CDATA[Ramos]]></surname>
<given-names><![CDATA[LR]]></given-names>
</name>
<name>
<surname><![CDATA[Araújo]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
<name>
<surname><![CDATA[Vieira]]></surname>
<given-names><![CDATA[JG]]></given-names>
</name>
<name>
<surname><![CDATA[Maeda]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
<name>
<surname><![CDATA[Borba]]></surname>
<given-names><![CDATA[VZ]]></given-names>
</name>
<name>
<surname><![CDATA[Kunii]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Hayashi]]></surname>
<given-names><![CDATA[LF]]></given-names>
</name>
<name>
<surname><![CDATA[Lazaretti-Castro]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Prevalence of vitamin D deficiency, insufficiency and secondary hyperparathyroidism in the elderly inpatients and living in the community of the city of São Paulo, Brazil]]></article-title>
<source><![CDATA[Arq Bras Endocrinol Metabol]]></source>
<year>2007</year>
<volume>51</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>437-442</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Holick]]></surname>
<given-names><![CDATA[MF]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Vitamin D requirements for humans of all ages: new increased requirements for women and men 50 years and older]]></article-title>
<source><![CDATA[Osteoporos Int]]></source>
<year>1998</year>
<volume>8</volume>
<numero>^s2</numero>
<issue>^s2</issue>
<supplement>2</supplement>
<page-range>S24-S29</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="">
<collab>National Institute of Standards and Technology (NIST) Chemical Science and Technology Laboratory</collab>
<source><![CDATA[NIST releases vitamin D standard reference material]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Isenor]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
<name>
<surname><![CDATA[Ensom]]></surname>
<given-names><![CDATA[MHH]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Is There a Role for Therapeutic Drug Monitoring of Vitamin D Level as a Surrogate Marker for Fracture Risk?]]></article-title>
<source><![CDATA[Pharmacotherapy]]></source>
<year>2010</year>
<volume>30</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>254-264</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
